Clinical Trial

Cardiovascular Protection After Preeclampsia With Enalapril

Name: Cardiovascular Protection After Preeclampsia With Enalapril — clinical trial record (NCT07222852)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CAPP-E

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to learn if postpartum women are willing to be randomized to different blood pressure medicines after delivery and how that affects blood pressure in women with hypertensive disorders of pregnancy.

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-07

Trial Details

NCT Number	NCT07222852
Lead Sponsor	Women and Infants Hospital of Rhode Island
Conditions	Preeclampsia, Hypertensive Disorder of Pregnancy, Hypertension, Gestational Hypertension, Gestational Hypertension After Childbirth
Enrollment	60 participants
Start Date	2026-01-01
Primary Completion	2027-10-15 (estimated)
Study Completion	2027-10-15 (estimated)
Updated on ClinicalTrials.gov	2026-08-06